insights_auto
Why is UTHR up 3.25%?
Dive Deeperchevron_right
UTHR:NASDAQ
United Therapeutics Corp
$550.11
arrow_upward
+3.25%(+17.33) 1D
Oct 9, 3:43:07 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$528.92
High
$551.15
Low
$528.92
Mkt. cap
23.60B
Avg. vol.
895.54K
Volume
337.42K
P/E ratio
19.68
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
Open
$528.92
High
$551.15
Low
$528.92
Mkt. cap
23.60B
Avg. vol.
895.54K
Volume
337.42K
P/E ratio
19.68
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Zacks
·
6 hours ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investing.com
·
15 hours ago
United Therapeutics chairperson & CEO Martine Rothblatt sells $5.2m in stock
Investing.com Nigeria
·
15 hours ago
Form 4 United Therapeutics Corporation For: 9 October By Investing.com
Simply Wall Street
·
18 hours ago
How Revenue Decline Fears At United Therapeutics Stock Have Changed Its Investment Story
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com